Target intelligence / Profile preview

N-acyl homoserine lactonase (AiiA) (AiiA)

Target
AiiA
Molecular classification
Enzyme, Hydrolase, Metallo-beta-lactamase superfamily
01

Overview

AiiA is a prominent N-acyl homoserine lactonase, first identified in Bacillus species, that serves as a key tool in quorum quenching strategies. It belongs to the metallo-beta-lactamase superfamily and requires two zinc ions for its catalytic activity, which involves the hydrolytic cleavage of the lactone ring in N-acyl homoserine lactones (AHLs) [Dong et al., 2000; Liu et al., 2005]. AHLs are essential signaling molecules used by many Gram-negative bacteria to coordinate group behaviors, including the expression of virulence factors and the formation of resilient biofilms [Grandclément et al., 2016]. By enzymatically degrading these signals, AiiA disrupts bacterial communication (quorum sensing), effectively attenuating the pathogenicity of organisms like Pseudomonas aeruginosa and Erwinia carotovora without exerting the strong selective pressure for resistance typical of traditional antibiotics [Dong et al., 2000]. This makes AiiA a significant candidate for therapeutic development in treating chronic infections and preventing biofouling in medical and industrial settings. While currently utilized primarily in agricultural and biotechnological research, its potential as a pathoblocker or anti-virulence agent represents a novel paradigm in managing multidrug-resistant bacterial diseases [Grandclément et al., 2016].

Other names
AHL lactonaseAHLaseN-acyl-L-homoserine lactone hydrolaseAutoinducer inactivation enzymeQuorum-quenching lactonase
02

Mechanism of action

Hydrolytic cleavage of the lactone ring in N-acyl homoserine lactones (AHLs), preventing them from binding to LuxR-type transcriptional regulators and thus inhibiting quorum-sensing-dependent gene expression [Dong et al., 2000; Liu et al., 2005].

03

Biological functions

Quorum quenchingHydrolysis of N-acyl homoserine lactonesRegulation of bacterial virulenceBiofilm inhibitionSignal degradation
04

Disease associations

Bacterial infectionBiofilm-associated infectionCystic fibrosisPlant soft rotInfection
05

Safety considerations

Immunogenicity of recombinant proteinPotential disruption of commensal bacterial signalingStability in physiological environmentsLack of human homologs reducing off-target toxicity risk
06

Interacting drugs

N-acyl homoserine lactones (substrates)

1 more in the full profile.

07

Biomarkers

N-acyl homoserine lactone levelsBiofilm densityVirulence factor expression (e.g., elastase, protease)

Beyond the preview

Go deeper on N-acyl homoserine lactonase (AiiA) (AiiA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-acyl homoserine lactonase (AiiA) (AiiA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call